O’Shea, T., & Druce, M. (2017). When should genetic testing be performed in patients with neuroendocrine tumours? Rev Endocr Metab Disord.
Citação norma ChicagoO’Shea, Triona, and Maralyn Druce. "When Should Genetic Testing Be Performed in Patients With Neuroendocrine Tumours?" Rev Endocr Metab Disord 2017.
ציטוט MLAO’Shea, Triona, and Maralyn Druce. "When Should Genetic Testing Be Performed in Patients With Neuroendocrine Tumours?" Rev Endocr Metab Disord 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.